Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

Ambulatory Blood Pressure Monitoring in Clinical Practice: A Review

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Robert C. Stanton, MD American Journal of Kidney Diseases

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index Suma Vupputuri, PhD, Caroline.

Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women Xuemei Sui, MD, MPH, PhD, Mark A. Sarzynski,

What Started This? Debilitating Longitudinally-extensive Myelitis

An Unusual Cause of Leg Ulcerations

The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study Ido Weinberg, Philimon Gona, Christopher.

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Prevalence of and Risk Factors.

Emilee R. Wilhelm-Leen, BA, Yoshio N. Hall, MD, Manjula K

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin-converting Enzyme Inhibitor Philip Kam-Tao Li, MD, Bonnie Ching-Ha Kwan, MBBS, Kai-Ming.

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Overview of Current Learning Theories for Medical Educators

Multimorbidity in Middle-Aged Adults with Cerebral Palsy

Improving Adherence for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Lindsay Sonstein, MD, Carlos Clark, DO, Susan Seidensticker,

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

Epidemiology of Myelodysplastic Syndromes

Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Peter A. McCullough,

Kaiser Permanente Creatinine Safety Program: A Mechanism to Ensure Widespread Detection and Care for Chronic Kidney Disease John J. Sim, MD, Mark P.

Incident Gout in Women and Association with Obesity in the Atherosclerosis Risk in Communities (ARIC) Study Janet W. Maynard, MD, MHS, Mara A. McAdams.

Chronic Kidney Disease in Diabetes

Tick Tock The American Journal of Medicine

Medical professionalism and the generation gap

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Jessica L. Lee, MD, MS, Esther S. Oh, MD, Rebecca W. Lee, MD, Thomas E

Assessment of FIBROSpect II to Detect Hepatic Fibrosis in Chronic Hepatitis C Patients Atif Zaman, MD, MPH, Hugo R. Rosen, MD, Ken Ingram, PA-C, Christopher.

TIA for the Internist The American Journal of Medicine

Gout in African Americans

Treatment of hepatitis C

Michael A. Weber, MD, George L

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women Xuemei Sui, MD, MPH, PhD, Mark A. Sarzynski,

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

Your Kidneys May Outlive You

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Salt and Hypertension American Journal of Kidney Diseases

Molly E. Waring, PhD, Jane S

Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.

The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population Claudine T. Jurkovitz, MD, MPH, Yang Qiu,

Robert C. Stanton, MD American Journal of Kidney Diseases

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Prevalence and Risk Factors for Erectile Dysfunction in the US

Effect of Spironolactone on Physical Performance in Older People with Self-reported Physical Disability Louise A. Burton, MD, Deepa Sumukadas, MD, Miles.

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

Ali Ahmed, MD, Gregg C. Fonarow, MD, Yan Zhang, MS, MSPH, Paul W

George L. Bakris, MD, John M. Burkart, MD, Eric D

Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP)

Sodium Intake and Mortality in the NHANES II Follow-up Study

A Post-cure Complication

Risk for Incident Renal Dialysis in a Managed Care Population

Denise M. Dupras, MD, PhD, Randall S. Edson, MD, Andrew J

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

Pseudopheochromocytoma Secondary to Brimonidine Ophthalmic Solution

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Racial and Ethnic Differences in Albuminuria in Individuals With Estimated GFR Greater Than 60 mL/min/1.73 m2: Results From the Kidney Early Evaluation.

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Presentation transcript:

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J. Collins, MD, Wendy W. Brown, MD, MPH, Michael J. Klag, MD, MPH, George L. Bakris, MD The American Journal of Medicine Volume 121, Issue 4, Pages 332-340 (April 2008) DOI: 10.1016/j.amjmed.2007.11.025 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Participant eligibility and recruitment. KEEP=Kidney Early Evaluation Program; eGFR=estimated glomerular filtration rate; ACR=albumin-to-creatinine ratio; BMI=body mass index. The American Journal of Medicine 2008 121, 332-340DOI: (10.1016/j.amjmed.2007.11.025) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 Prevalence, awareness, treatment, and control of hypertension to recommended systolic goal (<130 mm Hg) by chronic kidney disease stage. Note total cohort has an N=10,813. Prevalence is defined by systolic blood pressure≥130 mm Hg or diastolic blood pressure≥80 mm Hg or use of medication. All comparisons between stages for all categories at P<.0001. The American Journal of Medicine 2008 121, 332-340DOI: (10.1016/j.amjmed.2007.11.025) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 Prevalence, awareness, treatment, and control of hypertension in total cohort by chronic kidney disease stage with<140/90 mm Hg as a threshold. Note total cohort has an N=10,813. Prevalence of systolic blood pressure≥140 mm Hg or diastolic blood pressure≥90 mm Hg or use of medication. All comparisons between stages are significant to a P<.0001. BP=blood pressure. The American Journal of Medicine 2008 121, 332-340DOI: (10.1016/j.amjmed.2007.11.025) Copyright © 2008 Elsevier Inc. Terms and Conditions